Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Tel Aviv University, Petah Tikva, Israel.
Neuroimmunomodulation. 2011;18(2):117-22. doi: 10.1159/000321634. Epub 2010 Nov 17.
We have previously demonstrated the immunomodulatory activity of some selective serotonin reuptake inhibitors.
In this research, we performed an in vivo/ex vivo study to evaluate the potential immunosuppressive effect of sertraline in an experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
Mice (C57/bl EAE) were treated with sertraline (5 mg/kg) or dexamethasone (1 mg/kg) 7 days after EAE induction and then 3 times weekly (for 3 weeks).
Sertraline modestly improved the clinical score of EAE and attenuated the disease-induced weight loss. Sertraline also significantly decreased ex-vivo splenocyte viability, proliferation and secretion of pro-inflammatory cytokines in EAE mice.
We suggest that sertraline might be an add-on option for multiple sclerosis treatment.
我们之前已经证明了一些选择性 5-羟色胺再摄取抑制剂的免疫调节活性。
在这项研究中,我们进行了一项体内/体外研究,以评估舍曲林在多发性硬化症的实验性自身免疫性脑脊髓炎(EAE)模型中的潜在免疫抑制作用。
在 EAE 诱导后 7 天,用舍曲林(5mg/kg)或地塞米松(1mg/kg)治疗 C57/bl EAE 小鼠,然后每周 3 次(共 3 周)。
舍曲林轻度改善 EAE 的临床评分,并减轻疾病引起的体重减轻。舍曲林还显著降低了 EAE 小鼠脾细胞的体外活力、增殖和促炎细胞因子的分泌。
我们认为舍曲林可能是治疗多发性硬化症的一种附加选择。